International Clinical Trial: Efficacy of Vunakizumab in Patients with Moderate-to-Severe Plaque Psoriasis and Obesity: A Single-Center, Prospective Clinical Study

Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133562) titled 'Efficacy of Vunakizumab in Patients with Moderate-to-Severe Plaque Psoriasis and Obesity: A Single-Center, Prospective Clinical Study' on Sept. 29.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Shenzhen Second People's Hospital

Condition: Moderate-to-severe plaque psoriasis (psoriasis vulgaris) in patients with obesity

Intervention: Non-obesity Group:N/A

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-10-01

Target Sample Size: Non-obesity Group:60;Obesity Group:60;

Countries of Recruitment: China

To know more, visit https://www.chictr.org....